Molecularly targeted therapy: toxicity and quality of life considerations in advanced colorectal cancer

AS Ribecco, MS Pino, G Cipriani… - Expert Review of …, 2013 - Taylor & Francis
Colorectal cancer (CRC) is the third most common malignancy and cause of death from
cancer among adults worldwide. In recent years, the use of 5-fluorouracil-based regimens in …
被引用次数：16 相关文章

Molecularly targeted therapy: toxicity and quality of life considerations in advanced colorectal cancer

AS Ribecco, MS Pino, G Cipriani, C Marinozzi… - Expert Review of …, 2013 - go.gale.com
Colorectal cancer (CRC) is the third most common malignancy and cause of death from
cancer among adults, with over 450,000 new cases diagnosed in Europe each year and …

Molecularly targeted therapy: toxicity and quality of life considerations in advanced colorectal cancer.

AS Ribecco, MS Pino, G Cipriani… - Expert Review of …, 2013 - europepmc.org
Colorectal cancer (CRC) is the third most common malignancy and cause of death from
cancer among adults worldwide. In recent years, the use of 5-fluorouracil-based regimens in …

Molecularly targeted therapy: toxicity and quality of life considerations in advanced colorectal cancer

AS Ribecco, MS Pino, G Cipriani… - Expert Review of …, 2013 - search.proquest.com
Colorectal cancer (CRC) is the third most common malignancy and cause of death from
cancer among adults worldwide. In recent years, the use of 5-fluorouracil-based regimens in …

Molecularly targeted therapy: toxicity and quality of life considerations in advanced colorectal cancer

AS Ribecco, MS Pino, G Cipriani… - Expert review of …, 2013 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third most common malignancy and cause of death from
cancer among adults worldwide. In recent years, the use of 5-fluorouracil-based regimens in …